GEODE CAPITAL MANAGEMENT, LLC - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 95 filers reported holding ALBIREO PHARMA INC in Q3 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$7,200
-99.9%
333,211
+6.5%
0.00%0.0%
Q3 2022$6,054,000
-7.3%
312,744
-4.9%
0.00%0.0%
Q2 2022$6,528,000
-35.2%
328,701
-2.6%
0.00%0.0%
Q1 2022$10,067,000
+44.9%
337,493
+13.1%
0.00%0.0%
Q4 2021$6,947,000
-24.9%
298,292
+0.6%
0.00%0.0%
Q3 2021$9,251,000
-9.2%
296,520
+2.4%
0.00%0.0%
Q2 2021$10,183,000
+1.0%
289,459
+1.2%
0.00%
-50.0%
Q1 2021$10,080,000
+4.2%
285,978
+10.9%
0.00%0.0%
Q4 2020$9,676,000
+28.8%
257,975
+14.6%
0.00%
+100.0%
Q3 2020$7,514,000
+49.3%
225,181
+18.5%
0.00%0.0%
Q2 2020$5,033,000
+68.7%
190,031
+4.2%
0.00%0.0%
Q1 2020$2,984,000
-58.7%
182,286
-35.9%
0.00%0.0%
Q4 2019$7,230,000
+171.1%
284,426
+113.2%
0.00%0.0%
Q3 2019$2,667,000
-34.7%
133,398
+5.3%
0.00%0.0%
Q2 2019$4,084,000
+16.7%
126,679
+16.5%
0.00%0.0%
Q1 2019$3,501,000
-26.8%
108,716
-44.2%
0.00%0.0%
Q4 2018$4,780,000
+65.7%
194,868
+122.7%
0.00%0.0%
Q3 2018$2,884,000
-0.1%
87,512
+7.6%
0.00%0.0%
Q2 2018$2,886,000
+85.7%
81,296
+70.3%
0.00%0.0%
Q1 2018$1,554,000
+90.7%
47,736
+49.9%
0.00%
Q4 2017$815,000
+22.2%
31,8520.0%0.00%
Q3 2017$667,000
+22.2%
31,852
+20.0%
0.00%
Q2 2017$546,000
+66.0%
26,549
+93.1%
0.00%
Q1 2017$329,000
+41.2%
13,746
+4.5%
0.00%
Q4 2016$233,00013,1580.00%
Other shareholders
ALBIREO PHARMA INC shareholders Q3 2021
NameSharesValueWeighting ↓
Prosight Management, LP 514,082$11,973,0007.17%
Privium Fund Management B.V. 379,117$8,959,0001.78%
Birchview Capital, LP 113,000$2,632,0001.70%
Sio Capital Management, LLC 213,913$4,982,0001.50%
Perceptive Advisors 4,720,278$109,936,0000.85%
Chicago Capital, LLC 849,239$19,779,0000.74%
APOGEM CAPITAL LLC 38,601$899,0000.59%
Samsara BioCapital, LLC 100,000$2,329,0000.45%
Artal Group S.A. 600,000$13,974,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 458,011$10,667,0000.38%
View complete list of ALBIREO PHARMA INC shareholders